Stay informed with the latest litigation news. Explore now

Dupont Industrial Biosciences Usa competitive analysis

Latest publications and patents of Dupont Industrial Biosciences Usa New

Explore the latest publications and patents granted to Dupont Industrial Biosciences Usa, showcasing their recent innovations and technological advancements.

Last updated on: Sep 2, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Dupont Industrial Biosciences Usa

Jun 21, 2023Transesterified Furan Based Polyesters And Articles Made TherefromGranted And Under Opposition
Feb 24, 2021Enhanced Barrier Performance Via Blends Of Poly(Ethylene Furandicarboxylate) And Poly(Ethylene Terephthalate)Granted And Under Opposition

Explore patent oppositions filed by Dupont Industrial Biosciences Usa against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 4, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

A Process For Preparing A Polymer Having A 2,5-Furandicarboxylate Moiety Within The Polymer Backbone And Such (Co)PolymersFURANIXMar 24, 2021

Explore Dupont Industrial Biosciences Usa's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 4, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jun 21, 2023Transesterified Furan Based Polyesters And Articles Made Therefrom1
Feb 24, 2021Enhanced Barrier Performance Via Blends Of Poly(Ethylene Furandicarboxylate) And Poly(Ethylene Terephthalate)2

Latest PTAB cases involving Dupont Industrial Biosciences Usa New

Discover the latest PTAB cases involving Dupont Industrial Biosciences Usa, highlighting their recent legal challenges and patent disputes.

Top competitors of Dupont Industrial Biosciences Usa

Top competitors of Dupont Industrial Biosciences Usa based on patent oppositions.